Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsInvestigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospitalSystematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesDetection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolates from Trinidad & Tobago.Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in KoreaIn vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.VISA, hetero-VISA and VRSA: the end of the vancomycin era?Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II.Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions.Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients.Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significanceVancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients.Impact of reduced vancomycin MIC on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia.Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolatesVancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan.Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.
P2860
Q24646677-12778DBD-2F5A-40EC-8B71-11C2349E0F06Q24810927-9DC2DA19-F266-46F6-B7EC-3E7FEB763B71Q26796560-65F27830-82FC-4F7D-8F24-4E4FE1952237Q33613735-EE3FE8EA-5B1F-440B-9BAB-92E39872D480Q34983312-81966CEA-FA98-4C85-A2F7-091B047F9D30Q35026306-2F94DC17-FC36-440D-84FC-F97CBCD39993Q35124610-843202C2-791D-4010-9FCE-205B1F4EF8AFQ36099449-6EFC4D9F-C4A3-47DC-A3AE-2C0EAA07C9E2Q36170611-05AC11FD-4494-40EA-AF49-C68E57B93B99Q36490837-8E3D71C3-AD12-4340-A213-231170F70549Q36497964-C1905E95-874F-4875-B63D-9A632667CB4CQ36636699-16F6E1B8-9672-4ACF-B324-93529C07DE9CQ36692468-FABF4EA5-ED65-41BA-8015-20D2136B08B8Q36847287-4CCE9933-F118-41FE-8F00-D92A766F9150Q37058087-C3F8AB92-D1CE-44F1-AC00-0279896BFA0AQ37263399-B794A6C4-353C-410D-B03A-BA303DB83480Q37625238-7765AB2E-ED07-41E4-889C-B762D1997F0AQ37809666-921A3F1D-4428-430C-AA9B-FDA460D5D0A8Q42153532-D6A94EEF-DF17-4FA9-9A69-E45D54CC5BB1Q42555908-C58F606A-759A-4F2C-B7C4-38275637BF7AQ43117809-7DE70FD7-CDCE-4610-B053-936BA743AE2A
P2860
Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clonal spread of Staphylococcu ...... university hospital in Korea.
@ast
Clonal spread of Staphylococcu ...... university hospital in Korea.
@en
Clonal spread of Staphylococcu ...... university hospital in Korea.
@nl
type
label
Clonal spread of Staphylococcu ...... university hospital in Korea.
@ast
Clonal spread of Staphylococcu ...... university hospital in Korea.
@en
Clonal spread of Staphylococcu ...... university hospital in Korea.
@nl
prefLabel
Clonal spread of Staphylococcu ...... university hospital in Korea.
@ast
Clonal spread of Staphylococcu ...... university hospital in Korea.
@en
Clonal spread of Staphylococcu ...... university hospital in Korea.
@nl
P2093
P2860
P1476
Clonal spread of Staphylococcu ...... a university hospital in Korea
@en
P2093
Chik Hyun Pai
Hyang-Mi Mun
Yeon-Jung Pyo
P2860
P304
P356
10.1128/JCM.40.4.1376-1380.2002
P407
P577
2002-04-01T00:00:00Z